Rubén Zapata-Pérez, et al. Reduced nicotinamide mononucleotide is a new and potent NAD+ precursor in mammalian cells and mice. The Faseb Journal. 2021, 35, 4.
 Haiteng Deng, Yan Liu, and et al. Reduced Nicotinamide Mononucleotide (NMNH) Potently Enhances NAD+ and Suppresses Glycolysis, the TCA Cycle, and Cell Growth. Journal of Proteome Research. 2021, 20, 5, 2596-2606.